Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지

The alteration of the positive rate of cytomegalovirus IgG antibody among preschool period children

학령 전기 소아에서 거대세포바이러스 IgG 항체 양성률의 변동

  • Seo, Se-Young (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Park, Sang-Jun (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Hwang, Ja-Young (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Hahn, Seong-Hoon (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Kim, So-Young (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Kim, Hyun-Hee (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Lee, Wonbae (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
  • 서세영 (가톨릭대학교 의과대학 소아과학교실) ;
  • 박상준 (가톨릭대학교 의과대학 소아과학교실) ;
  • 황자영 (가톨릭대학교 의과대학 소아과학교실) ;
  • 한승훈 (가톨릭대학교 의과대학 소아과학교실) ;
  • 김소영 (가톨릭대학교 의과대학 소아과학교실) ;
  • 김현희 (가톨릭대학교 의과대학 소아과학교실) ;
  • 이원배 (가톨릭대학교 의과대학 소아과학교실)
  • Received : 2005.08.11
  • Accepted : 2005.10.06
  • Published : 2006.01.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : In order to evaluate the time of disappearance of cytomegalovirus(CMV) IgG antibodies from mothers, and the alteration of the positive rate of CMV IgG antibodies among preschool period children, we investigated the positive rate of CMV antibodies among preschool children. Methods : We studied 391 children who visited the Department of Pediatrics from March, 2001 to February, 2004. We measured the serum CMV IgG of 217 children and the serum CMV IgM of 358 children. Results : The positive rate of CMV IgG antibodies is 83.9 percent(the number of positive IgG children is 182 out of 217). The alteration of the positive rate is 92.9 percent in 0-3 months, 75.0 percent in 4-6 months and the nadir was 20.0 percent in 7-9 months. Then, the positive rate increased to 83.9 percent in 22-24 months. After 22 months, the positive rate was 92.1 percent(the number of positive IgG children was 105 out of 114). The positive rate of CMV IgM antibody by age is 3.3 percent in 0-1 months, 3.6 percent in 1-2 months, 10.5 percent in 2-3 months, 14.3 percent in 3-4 months, 14.3 percent in 4-5 months, and then the results of five children among 148 children were positive. The distribution was one in 22-23 months, one in 25-26 months, one in 27-28 months, one in 28-29 months, one in 40-41 months. We discovered IgM positive children succesively from birth to 5 months, but sporadically after 5 months. Conclusion : The CMV IgG from mothers has decreased since birth and the time of nadir is 7-9 months. But it increases to a mean value of 83.9 percent at 22-24 months because of perinatal or postnatal infections.

목 적 : 학령 전기 소아에서 연령에 따른 거대세포바이러스 항체 보유율의 조사를 통해 모체로부터 유래된 항체의 소실 시기와 후천적 감염에 의한 항체 양성률이 증가되는 시기를 알아 보기 위해 본 연구를 실시하였다. 방 법 : 2001년 3월부터 2004년 2월까지 가톨릭대학교 성가병원에 내원한 신생아부터 만 5세(60개월)까지 연령의 391명을 대상으로 하였다. 이 중에서 217명은 거대세포바이러스 IgG를 검사하였고, 358명은 거대세포바이러스 IgM를 검사하였다. 결 과 : 학령 전기 소아의 혈청내 거대세포바이러스 IgG 항체양성률은 전체 대상자 217명 중 182명이 양성을 보여 평균 83.9%의 양성률을 보였다. 전체적인 변동은 출생시부터 3개월까지 나이에서 92.9%를 보인 후 생후 4-6개월 사이에서 75.0%로 감소되었으며 생후 7-9개월 사이에서 20.0%로 최저치를 보인 후 차츰 증가하여 생후 22-24개월 사이에 전체 평균인 83.9%에 근접한 수치에 도달하였다. 25개월 이후부터는 전체 평균치보다 높은 양성률을 보였다. 생후 22개월 이후에는 총 114명 중 105명이 양성을 보여 92.1%의 양성률을 보였다. 거대세포바이러스 IgM 항체 양성률은 전체 대상자 358명 중에서 0-1개월의 150명 중 3명이 양성으로 3.3%, 1-2개월의 28명 중 1명이 양성으로 3.6%, 2-3개월의 19명 중 2명이 양성으로 10.5%, 3-4개월의 7명 중 1명이 양성으로 14.3%, 4-5개월의 7명 중 1명이 양성으로 14.3%였고, 이후에는 148명 중 5명만이 양성인데, 22-23개월에 1명, 25-26개월에 1명, 27-28개월에 1명, 28-29개월에 1명, 40-41개월에 1명씩 분포하여 출생 후부터 생후 5개월까지는 지속적으로 발견되었으나, 이후 연령에서는 간헐적으로 발견되었다. 결 론 : 거대세포바이러스 IgG 항체는 모체에서 유래된 IgG 항체는 출생 후부터 감소되어 생후 7-9개월경 급격히 감소되며 주산기 또는 출생 직후부터의 거대세포바이러스 감염에 의해 IgG가 증가되어 생후 22-24개월에 평균 IgG 양성률인 83.9%에 도달한다.

Keywords

References

  1. Nigro G, Anceschi MM, Cosmi EV. Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection. BJOG 2003;110:572-7 https://doi.org/10.1046/j.1471-0528.2003.01302.x
  2. Seehofer D, Rayes N, Tullius SG, Schmidt CA, Neumann UP, Radke C, et al. CMV hepatitis after liver transplantation : incidence, clinical course, and long-term follow-up. Liver Transpl 2002;8:1138-46 https://doi.org/10.1053/jlts.2002.36732
  3. Just-Nubling G, Korn S, Ludwig B, Stephan C, Doerr HW, Preiser W. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects. Infection 2003;31:318-23
  4. Daiminger A, Bader U, Enders G. Pre- and periconceptional primary cytomegalovirus infection : risk of vertical transmission and congenital disease. Obstet Gynecol Surv 2005;60:420-2 https://doi.org/10.1097/01.ogx.0000167218.01115.6a
  5. Nigro G, Mazzocco M, Anceschi MM, La Torre R, Antonelli G, Cosmi EV. Prenatal diagnosis of fetal cytomegalovirus infection after primary or recurrent maternal infection. Obstet Gynecol 1999;94:909-14 https://doi.org/10.1016/S0029-7844(99)00473-1
  6. Grangeot-Keros L, Mayaux MJ, Lebon P, Freymuth F, Eugene G, Stricker R, et al. Value of cytomegalovirus(CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis 1997;175:944-6 https://doi.org/10.1086/513996
  7. de Ory F, Ramirez R, Garcia Comas L, Leon P, Sagues MJ, Sanz JC. Is there a change in cytomegalovirus seroepidemiology in Spain? Eur J Epidemiol 2004;19:85-9 https://doi.org/10.1023/B:EJEP.0000013253.56343.6f
  8. Lee KY. Seroepidemiology of cytomegalovirus in Taejon, Korea, in 1996. J Korean Pediatr Soc 1998;41:754-9
  9. Kakizawa H, Okumura A, Suzuki Y, Natsume J, Kimura H, Negoro T, et al. Congenital cytomegalovirus infection diagnosed by polymerase chain reaction with the use of preserved umbilical cord. Pediatr Infect Dis J 2005;24:653-4 https://doi.org/10.1097/01.inf.0000168842.56185.cd
  10. Wentworth BB, Alexander ER. Seroepidemiology of infectious due to members of the herpesvirus group. Am J Epidemiol 1971;94:496-507 https://doi.org/10.1093/oxfordjournals.aje.a121347
  11. Wenzel RP, McCormick DP, Davies JA, Berling C, Beam WE Jr. Cytomegalovirus infection : a seroepidemiologic study of a recruit population. Am J Epidemiol 1973;97:410- 4 https://doi.org/10.1093/oxfordjournals.aje.a121522
  12. Bale JF Jr, Petheram SJ, Souza IE, Murph JR. Cytomegalovirus reinfection in young children. J Pediatr 1996;128:347- 52 https://doi.org/10.1016/S0022-3476(96)70279-2
  13. Nagy A, Endreffy E, Streitman K, Pinter S, Pusztai R. Incidence and outcome of congenital cytomegalovirus infection in selected groups of preterm and full-term neonates under intensive care. In Vivo 2004;18:819-23
  14. Kothari A, Ramachandran VG, Gupta P, Singh B, Talwar V. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India. J Health Popul Nutr 2002;20: 348-51
  15. Diosi P, Moldovan E, Tomescu N. Latent cytomegalovirus infection in blood donors. Br Med J 1969;4:660-2 https://doi.org/10.1136/bmj.4.5684.660
  16. Krech UH, Jung M, Jung F. Cytomegalovirus infection of man. 2nd ed. Philadelphia : WB Saunders Co, 1987:1558-64
  17. Jawets E, Melinick JL, Adelberg ZA : Cytomegalovirus review of medical microbiology. 16th ed. Los Angeles : Lange Medical Publication, 1984:475-6
  18. Sim YK. A serological survey for CMV CF antibody among voluntary blood donors in Seoul area. Korean J Epidemiol 1981;3:99-104
  19. Beyari MM, Hodgson TA, Kondowe W, Molyneux EM, Scully C, Porter SR, et al. Inter- and intra-person cytomegalovirus infection in Malawian families. J Med Virol 2005;75:575-82 https://doi.org/10.1002/jmv.20312
  20. Yow MD, White NH, Taber LH, Frank AL, Gruber WC, May RA, et al. Acquisition of cytomegalovirus infection from birth to 10 years : a longitudinal serologic study. J Pediatr 1987;110:37-42 https://doi.org/10.1016/S0022-3476(87)80284-6
  21. Stern H, Tucker SM. Prospective study of cytomegalovirus infection in pregnancy. Br Med J 1973;2:268-70 https://doi.org/10.1136/bmj.2.5861.268
  22. Kim DW, No KU, Kim MJ, Park SM, Kim HS, Chang YP, et al. Transfusion-acquired cytomegalovirus infections in two premature infants. J Korean Pediatr Soc 1992;35:1141- 7
  23. Rosenthal SL, Stanberry LR, Biro FM, Slaoui M, Francotte M, Koutsoukos M, et al. Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents. Clin Infect Dis 1997;24:135-9 https://doi.org/10.1093/clinids/24.2.135
  24. Kumar A, Madden DL, Nankervis GA. Humoral and cellmediated immune responses to herpesvirus antigens during pregnancy-a longitudinal study. J Clin Immunol 1984;4: 12-7 https://doi.org/10.1007/BF00915281
  25. Mackowiak PA, Haley ML, Marling-Cason M, Tiemens KM, Luby JP. Effect of human sex hormones on cytomegalovirus growth and Fc receptor expression. J Lab Clin Med 1987;110:427-32
  26. Meier J, Lienicke U, Tschirch E, Kruger DH, Wauer RR, Prosch S. Human cytomegalovirus reactivation during lactation and mother-to-child transmission in preterm infants. J Clin Microbiol 2005;43:1318-24 https://doi.org/10.1128/JCM.43.3.1318-1324.2005
  27. Kakizawa H, Okumura A, Suzuki Y, Natsume J, Kimura H, Negoro T, et al. Congenital cytomegalovirus infection diagnosed by polymerase chain reaction with the use of preserved umbilical cord. Pediatr Infect Dis J 2005;24:653-4 https://doi.org/10.1097/01.inf.0000168842.56185.cd
  28. Griffiths PD, Stagno S, Pass RF, Smith RJ, Alford CA Jr. Infection with cytomegalovirus during pregnancy : specific IgM antibodies as a marker of recent primary infection. J Infect Dis 1982;145:647-53 https://doi.org/10.1093/infdis/145.2.647
  29. Griffiths PD, Stagno S, Pass RF, Smith RJ, Alford CA Jr. Congenital cytomegalovirus infection : diagnostic and prognostic significance of the detection of specific immunoglobulin M antibodies in cord serum. Pediatrics 1982;69:544-9
  30. Gleaves CA, Hursh DA, Rice DH, Meyers JD. Detection of cytomegalovirus from clinical specimens in centrifugation culture by in situ DNA hybridization and monoclonal antibody staining. J Clin Microbiol 1989;27:21-3
  31. Reynolds DW, Stagno S, Reynolds R, Alford CA Jr. Perinatal cytomegalovirus infection : influence of placentally transferred maternal antibody. J Infect Dis 1978;137:564-7 https://doi.org/10.1093/infdis/137.5.564
  32. Adler SP. Cytomegalovirus and pregnancy. Curr Opin Obstet Gynecol 1992;4:670-5
  33. Schneeberger PM, Groenendaal F, de Vries LS, van Loon AM, Vroom TM. Variable outcome of a congenital cytomegalovirus infection in a quadruplet after primary infection of the mother during pregnancy. Acta Paediatr 1994; 83:986-9 https://doi.org/10.1111/j.1651-2227.1994.tb13189.x
  34. Mussi-Pinhata MM, Yamamoto AY, do Carmo Rego MA, Pinto PC, da Motta MS, Calixto C. Perinatal or early-postnatal cytomegalovirus infection in preterm infants under 34 weeks gestation born to CMV-seropositive mothers within a high-seroprevalence population. J Pediatr 2004;145:685-8 https://doi.org/10.1016/j.jpeds.2004.07.025